News Detail
New Delhi, 22 Sept 2023: The Subject Expert Committee (SEC) on vaccines, which reviews proposals and advice the Drugs Controller General (India) (DCGI) in matters for biologicals and post approval change proposals, has recommended to grant permission to Gujarat-based Cadila Pharm......
View Details
Source : Pharmabiz
Subject Expert Committee
SEC
DCGI
biological
Cadila Pharmaceuticals
Varicella-Zoster Virus
VZV vaccine
New Drugs and Clinical Trials Rules
2019
WHO
Varicella
chickenpox
varicella-zoster virus
herpesvirus
Oka VZV
MMRV
ThRabis
Related News
- Illegally selling medicines in a under construction house in Bhopal, seized 22 type of drugs (06-10-2024)
- Gilead Sciences agrees to license new HIV prevention drug to 120 countries (06-10-2024)
- Five sentenced to 10 year rigorous imprisonment for smuggling Ketamine (06-10-2024)
- Treated by fake doctor without MBBS who was working as RMO for five years (06-10-2024)
- 'Create rare diseases fund': Delhi HC to Centre (06-10-2024)
- 10th pass Ramkishore of Bandikui became doctor by putting photo on the documents of Ramkishore of Dungarpur (06-10-2024)
- Fake call centres selling Viagra, duping people in loan fraud busted, 36 arrested (05-10-2024)
- SHEOHAR: Raid on illegal nursing home and medical shop, medicines worth Rs 5 lakh seized (05-10-2024)
- Iron tablets prime target of illegal med producers (05-10-2024)
- DEA Issues Warning About Illegal Online Pharmacies (05-10-2024)